Boehringer Ingelheim Biopharmaceuticals

Boehringer Ingelheim Biopharmaceuticals, operating under the BioXcellence brand, is the contract development and manufacturing arm of Boehringer Ingelheim and one of the worlds leading biopharmaceutical CDMOs. With sites in Biberach (Germany), Vienna, Fremont (USA) and Shanghai, the company offers mammalian and microbial cell culture manufacturing at scales from 2,000 up to 15,000 litres, fully licensed by EMA, FDA and MHLW.